-
Je něco špatně v tomto záznamu ?
S-adenosylmethionine exerts a protective effect against thioacetamide-induced injury in primary cultures of rat hepatocytes
Lotková H, Cervinková Z, Kucera O, Rousar T, Kriváková P
Jazyk angličtina Země Velká Británie
- MeSH
- alternativy testů na zvířatech MeSH
- antagonismus léků MeSH
- financování organizované MeSH
- glutathion metabolismus MeSH
- hepatocyty enzymologie účinky léků MeSH
- karcinogeny toxicita MeSH
- krysa rodu rattus MeSH
- kultivované buňky MeSH
- L-laktátdehydrogenasa metabolismus MeSH
- membránový potenciál mitochondrií účinky léků MeSH
- nekróza chemicky indukované prevence a kontrola MeSH
- ochranné látky farmakologie MeSH
- peroxidace lipidů účinky léků MeSH
- potkani Wistar MeSH
- S-adenosylmethionin farmakologie MeSH
- thioacetamid toxicita MeSH
- viabilita buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
S-adenosylmethionine (SAMe) has been shown to protect hepatocytes from toxic injury, both experimentally-induced in animals and in isolated hepatocytes. The mechanisms by which SAMe protects hepatocytes from injury can result from the pathways of SAMe metabolism. Unfortunately, data documenting the protective effect of SAMe against mitochondrial damage from toxic injury are not widely available. Thioacetamide is frequently used as a model hepatotoxin, which causes in vivo centrilobular necrosis. Even though thioacetamide-induced liver necrosis in rats was alleviated by SAMe, the mechanisms of this protective effect remain to be verified. The aim of our study was to determine the protective mechanisms of SAMe on thioacetamide-induced hepatocyte injury by using primary hepatocyte cultures. The release of lactate dehydrogenase (LDH) from cells incubated with thioacetamide for 24 hours, was lowered by simultaneous treatment with SAMe, in a dose-dependent manner. The inhibitory effect of SAMe on thioacetamide-induced lipid peroxidation paralleled the effect on cytotoxicity. A decrease in the mitochondrial membrane potential, as determined by Rhodamine 123 accumulation, was also prevented. The attenuation by SAMe of thioacetamide-induced glutathione depletion was determined after subsequent incubation periods of 48 and 72 hours. SAMe protects both cytoplasmic and mitochondrial membranes. This effect was more pronounced during the development of thioacetamide-induced hepatocyte injury that was mediated by lipid peroxidation. Continuation of the SAMe treatment then led to a reduction in glutathione depletion, as a potential consequence of an increase in glutathione production, for which SAMe is a precursor.
Citace poskytuje Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10001074
- 003
- CZ-PrNML
- 005
- 20111210154933.0
- 008
- 100118s2007 xxk e eng||
- 009
- AR
- 024 __
- $a 10.1177/026119290703500309 $2 doi
- 035 __
- $a (PubMed)17650956
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Lotková, Halka, $d 1967- $7 xx0076217
- 245 10
- $a S-adenosylmethionine exerts a protective effect against thioacetamide-induced injury in primary cultures of rat hepatocytes / $c Lotková H, Cervinková Z, Kucera O, Rousar T, Kriváková P
- 314 __
- $a Department of Physiology, Charles University in Prague, Faculty of Medicine in Hradec Krávlové, Czech Republic. lotko@lfhk.cuni.cz
- 520 9_
- $a S-adenosylmethionine (SAMe) has been shown to protect hepatocytes from toxic injury, both experimentally-induced in animals and in isolated hepatocytes. The mechanisms by which SAMe protects hepatocytes from injury can result from the pathways of SAMe metabolism. Unfortunately, data documenting the protective effect of SAMe against mitochondrial damage from toxic injury are not widely available. Thioacetamide is frequently used as a model hepatotoxin, which causes in vivo centrilobular necrosis. Even though thioacetamide-induced liver necrosis in rats was alleviated by SAMe, the mechanisms of this protective effect remain to be verified. The aim of our study was to determine the protective mechanisms of SAMe on thioacetamide-induced hepatocyte injury by using primary hepatocyte cultures. The release of lactate dehydrogenase (LDH) from cells incubated with thioacetamide for 24 hours, was lowered by simultaneous treatment with SAMe, in a dose-dependent manner. The inhibitory effect of SAMe on thioacetamide-induced lipid peroxidation paralleled the effect on cytotoxicity. A decrease in the mitochondrial membrane potential, as determined by Rhodamine 123 accumulation, was also prevented. The attenuation by SAMe of thioacetamide-induced glutathione depletion was determined after subsequent incubation periods of 48 and 72 hours. SAMe protects both cytoplasmic and mitochondrial membranes. This effect was more pronounced during the development of thioacetamide-induced hepatocyte injury that was mediated by lipid peroxidation. Continuation of the SAMe treatment then led to a reduction in glutathione depletion, as a potential consequence of an increase in glutathione production, for which SAMe is a precursor.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a alternativy testů na zvířatech $7 D000826
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a karcinogeny $x toxicita $7 D002273
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a antagonismus léků $7 D004336
- 650 _2
- $a glutathion $x metabolismus $7 D005978
- 650 _2
- $a hepatocyty $x enzymologie $x účinky léků $7 D022781
- 650 _2
- $a L-laktátdehydrogenasa $x metabolismus $7 D007770
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránový potenciál mitochondrií $x účinky léků $7 D053078
- 650 _2
- $a nekróza $x chemicky indukované $x prevence a kontrola $7 D009336
- 650 _2
- $a ochranné látky $x farmakologie $7 D020011
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a S-adenosylmethionin $x farmakologie $7 D012436
- 650 _2
- $a thioacetamid $x toxicita $7 D013853
- 700 1_
- $a Červinková, Zuzana, $d 1951- $7 nlk20020106444
- 700 1_
- $a Kučera, Otto, $d 1977- $7 xx0041536
- 700 1_
- $a Roušar, Tomáš. $7 ola2012695942
- 700 1_
- $a Křiváková, Pavla, $d 1979- $7 stk2008428620
- 773 0_
- $w MED00000610 $t ATLA $g Roč. 35, č. 3 (2007), s. 363-371 $x 0261-1929
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100114083259 $b ABA008
- 991 __
- $a 20100118165053 $b ABA008
- 999 __
- $a ok $b bmc $g 704722 $s 567288
- BAS __
- $a 3
- BMC __
- $a 2007 $b 35 $c 3 $d 363-371 $i 0261-1929 $m ATLA. Alternatives to laboratory animals $x MED00000610
- LZP __
- $a 2010-b1/vtme